Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation

Hypertension

Volumn 44, Issue 3, 2004, Pages 340-345

  Xiao, Fang ^a   Puddefoot, John R ^a   Barker, Stewart ^a   Vinson, Gavin P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotensin II; Hypertension, essential; Mineralocorticoids; Muscle, smooth, vascular; Receptors, angiotensin

Indexed keywords

18 HYDROXYDEOXYCORTICOSTERONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; CORTICOSTERONE; ENZYME INHIBITOR; MESSENGER RNA; MINERALOCORTICOID; STEROID 11BETA MONOOXYGENASE; THYMIDINE DERIVATIVE; THYMIDINE H 3; TRILOSTANE; TRITIUM; UNCLASSIFIED DRUG;

ALDOSTERONE RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ESSENTIAL HYPERTENSION; GENETIC TRANSCRIPTION; HORMONE ACTION; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; ANIMALS; CELL DIVISION; CELLS, CULTURED; CORTICOSTERONE; DESOXYCORTICOSTERONE; DNA REPLICATION; DRUG SYNERGISM; GENE EXPRESSION PROFILING; MALE; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID 11-BETA-HYDROXYLASE; STIMULATION, CHEMICAL; TRANSCRIPTION, GENETIC; ZONA FASCICULATA; ZONA GLOMERULOSA;

EID: 4444259683     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000140771.21243.ed     Document Type: Article

References (31)

1. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone-Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994;269: 24316-24320.
2. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B. Mouas C, Moalic JM, Swynghedauw B, Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. J Biol Chem. 1998;273:4883-4891.
3. Müller J. Regulation of aldosterone biosynthesis: the end of the road? Clin Exp Pharmacol Physiol. 1998;25:S79-S85.
4. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens. 1999;12: 205S-213S.
5. Huckle WR, Earp HS. Regulation of cell proliferation and growth by angiotensin II. Progr Growth Factor Res. 1994;5:177-194.
6. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev. 2001;81:999-1030.
7. Rosendorff C. Vascular hypertrophy in hypertension: role of the renin-angiotensin system. Mt Sinai J Med. 1998;65:108-117.
8. Jahan H, Kobayashi S, Nishimural J. Kanaide H. Endithelin-1 and angiotensin II act as progression but not competence growth factors in vascular smooth muscle cells. Eur J Pharmacol. 1996:295:261-269.
9. Viswanathan M, Stromberg C, Seltzer A, Saavedra JM. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest. 1992;90:1707-1712.
10. Ichiki T, Takeda K, Tokunou T, Lino N, Egashira K, Shimokawa H, Hirano K, Kanaide H, Takeshita A. Downregulation of angiotensin II type I receptor by hydrophobic 3-hydroxy-3-methylylutaryl coenzyme a reductase inhibitors in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:1896-1901.
11. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 1990:67: 1355-1364.
12. Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol. 1995;269: E657-E662.
13. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002:283:H1802-H1810.
14. Bravo EL. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease. Curr Hypertens Rep. 2003;5: 122-125.
15. Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab. 1996;81:2797-2800.
16. Takeda Y, Miyamori I, Yoneda T. Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinol. 1994;135:2283-2286.
17. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF, Gomez-Sanchez EP. Aldosterone Biosynthesis in the rat brain. Endocrinol. 1997;138:3369-3373.
18. Xiao F, Puddefoot JR, Vinson GP. Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation. J Endocrinol. 2000;165:533-536.
19. Ullian ME. Hutchison FN, Hazen-Martin DJ, Morinelli TA. Angiotensin II-aldosterone interaction on protein synthesis in vascular smooth muscle cells. Am J Phvsiol. 1993;264:C1525-C1531.
20. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone-Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994;269(39): 24316-24320.
21. Kapas S. Orford CD, Barker S, Vinson GP, Hinson JP, Studies on the intracellular mechanism of action of alpha-melanocyte-stimulating hormone on rat adrenal zona glomerulosa. J Mol Endocrinol. 1992; 9(1): 47-54.
22. Mcpherson MJ, Hames BD. Taylor GR. PCR 2: A Practical Approach. New York: Oxford University Press Inc.; 1995.
23. Nonaka Y. Okamoto M. Functional expression of the cDNA encoding rat 11β-hydroxylase [cytochrome P450(11β] and aldosterone synthase [cytochrome P450(11β, aldo)]. Eur J Biochem. 1991;202:897-902.
24. Xiao F, Puddefoot JR. Vinson GP. The expression of renin and the formation of angiotensin II in bovine aortic endothelial cells. J Endocrinol. 2000 164:207-214.
25. Shin-ichi O, Hori S. Sano R, Suzuki N. Fujii Y, Abe R, Goto Y. Effect of low density lipoprotein on DNA synthesis of cultured human arterial SMC. Atherosclerosis. 1987;64:7-12.
26. Duprez D, De BM, Rietzschel ER, Clement DL. Aldosterone and vascular damage. Curr Hypertens Rep. 2000;2:327-334.
27. 1 receptor by tanscriptional and posttranscriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601-609.
28. Della Bruna R, Ries S, Himmelstoss C, Kurtz A. Expression of cardiac angiotensin II AT1 receptor genes in rat hearts is regulated by steroid but not by angiotensin II. J Hypertens. 1995;13:763-769.
29. Robert V, Heymes C, Silvestre JS, Sabri A, Swynghedauw B, Delcayre C, Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension. 1999;33:981-986.
30. Wang DH, Qiu J, Hu Z. Differential regulation of angiotensin II receptor subtypes in the adrenal gland: role of aldosterone. Hypertension. 1998: 32:65-70.
31. Pitt B. Aldosterone blockade in patients with systolic left ventricular dysfunction. Circulation. 2003;108:1790-1794.